Author:
Arjunan Durairaj,Bhadada Tushar,Mohankumar Subasri B,Bhadada Sanjay Kumar
Publisher
Springer Science and Business Media LLC
Subject
Orthopedics and Sports Medicine
Reference35 articles.
1. Drake, M. T., Clarke, B. L., & Khosla, S. (2008). Bisphosphonates: Mechanism of action and role in clinical practice. Mayo Clinic Proceedings, 83(9), 1032–1045.
2. De Rosa, G., Misso, G., Salzano, G., & Caraglia, M. (2013). Bisphosphonates and cancer: What opportunities from nanotechnology? Journal of Drug Delivery, 2013, 637976. https://doi.org/10.1155/2013/637976(Epub 2013 Mar 4).
3. Heymann, D. (2010). Bisphosphonates and bone diseases: Past, present and future. Current Pharmaceutical Design, 16(27), 2948–2949.
4. Grey, A., & Reid, I. R. (2006). Differences between the bisphosphonates for the prevention and treatment of osteoporosis. Therapeutics and Clinical Risk Management, 2(1), 77–86.
5. McGreevy, C., & Williams, D. (2011). Safety of drugs used in the treatment of osteoporosis. Therapeutic Advances in Drug Safety, 2(4), 159–172.